ArticleCureus2025
Atypical Calciphylaxis Following Parathyroidectomy and Persistent Severe Hypocalcemia in a Hemodialysis Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcific uremic arteriolopathy (CUA) or calciphylaxis is a rare disorder involving painful necrosis of the skin secondary to calcification and thrombosis of small arterioles in patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD). Such events may even occur after parathyroidectomy (PTX), typically in the setting of adynamic bone disease and very low post-PTX parathyroid hormone (PTH) levels. In this report, we describe a 40-year-old woman with ESRD from IgA nephropathy who developed diffuse, painful subcutaneous calcifications that progressed gradually over several weeks, about 10 months after PTX for severe secondary hyperparathyroidism, evolving into a spontaneous ulceration on the left lateral thigh. Pre-PTX, she had a PTH value of 1389.6 pg/mL, but serum corrected calcium was only 7.3 mg/dL. Her postoperative course was complicated by worsening hypocalcemia, a prolonged need for intravenous calcium infusion after PTX consistent with hungry bone syndrome, and ongoing hyperphosphatemia with phosphorus persistently ranging from 6 to 8 mg/dL. Hungry bone-associated hypocalcemia typically requires weeks to months to stabilize, as was the case with this patient, and supplementation is generally titrated to maintain calcium in the low-normal range while avoiding excessive calcium loading. This patient continues to have chronic pain and poor wound healing despite numerous therapies. This case is intended to show the paradox of calciphylaxis in low PTH states and demonstrate the complex interplay of suppressed bone turnover and calcium dysregulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.